CXCL8 and melanoma: To study the impact of these inhibitors on inflammation, we measured the transcript levels of interleukin 8 (IL-8, gene CXCL8), a chemokine linked to melanoma progression, phenotype switching and resistance (reviewed in Filimon et al [2021]).